Haisco Pharmaceutical Group Co., Ltd.

This study tests an experimental inhaled drug called HSK39004 in 12 adults with COPD. The goal is to measure how the drug moves through the body and how it affects lung function over 12 hours. Participants receive the drug and a control treatment in a crossover design to compare …

This study tests a new dry powder inhaler called HSK39004 in 180 adults aged 40–80 with chronic obstructive pulmonary disease (COPD). Participants are randomly assigned to receive either the active inhaler or a placebo for 4 weeks. The main goal is to see if the drug improves lun…

This study tests a new medicine called HSK39004, given as an inhaler, for people with chronic obstructive pulmonary disease (COPD). About 50 adults aged 40 to 80 with COPD will receive either the new inhaler or a placebo. The main goal is to see if the drug improves lung function…

This study looks at how the drug itraconazole changes the way the body processes another drug called HSK31858. It involves 24 healthy adults aged 18 to 45. The goal is to measure drug levels in the blood, not to treat any disease.

This study looks at how the drug rifampicin changes the way another drug, HSK31858, is processed in the body. It involves 24 healthy adults aged 18 to 45. The goal is to measure drug levels in the blood, not to treat any disease.